November 2024s Leading Growth Stocks With Strong Insider Ownership - Yahoo Finance
| 688050 Stock | 88.52 0.18 0.20% |
About 53% of Eyebright Medical's investor base is interested to short. The analysis of overall sentiment of trading Eyebright Medical Technology stock suggests that many investors are impartial at this time. The current market sentiment, together with Eyebright Medical's historical and current headlines, can help investors time the market. In addition, many technical investors use Eyebright Medical stock news signals to limit their universe of possible portfolio assets.
Eyebright |
November 2024s Leading Growth Stocks With Strong Insider Ownership Yahoo Finance
Read at news.google.com
 |
Eyebright Medical Fundamental Analysis
We analyze Eyebright Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Eyebright Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Eyebright Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
EBITDA
EBITDA Comparative Analysis
Eyebright Medical is currently under evaluation in ebitda category among its peers. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Eyebright Medical Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Eyebright Medical stock to make a market-neutral strategy. Peer analysis of Eyebright Medical could also be used in its relative valuation, which is a method of valuing Eyebright Medical by comparing valuation metrics with similar companies.
Peers
Eyebright Medical Related Equities
| 601615 | Ming Yang | 2.75 | ||||
| 300729 | Loctek Ergonomic | 0.83 | ||||
| 601336 | New China | 0.52 | ||||
| 002096 | Hunan Nanling | 0.84 | ||||
| 002952 | Yes Optoelectronics | 5.47 | ||||
| 300243 | Shandong Ruifeng | 5.67 | ||||
| 002999 | Guangdong Tianhe | 6.04 |
Complementary Tools for Eyebright Stock analysis
When running Eyebright Medical's price analysis, check to measure Eyebright Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eyebright Medical is operating at the current time. Most of Eyebright Medical's value examination focuses on studying past and present price action to predict the probability of Eyebright Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eyebright Medical's price. Additionally, you may evaluate how the addition of Eyebright Medical to your portfolios can decrease your overall portfolio volatility.
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |